Skip to main content

Security report for pharmamanufacturing.com

Pharma Manufacturing · Manufacturing · N/a

Medium risk. 6 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

66/100

Risk levelMedium

0–100, higher is better. How it is calculated

Pharma Manufacturing is a specialized media platform providing news, analysis, and resources focused on pharmaceutical manufacturing, drug development, and biomanufacturing. It serves industry professionals by delivering timely content including webinars, podcasts, ebooks, and a magazine. The website demonstrates a modern technical infrastructure built on Vue.js and Nuxt.js frameworks, with good mobile optimization and SEO practices. Security posture is solid with HTTPS, security headers, and cookie consent mechanisms, though explicit security policies and incident response details are absent. The domain WHOIS data is missing, raising concerns about domain registration legitimacy. Overall, the site is professional and trustworthy in content but would benefit from improved transparency in security and contact information.

Scanned

NIS2 and GDPR posture

GDPR outside view
70/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching pharmamanufacturing.com

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
65
Security headers
15
Email security
70
DNS health
75
Network security
100
GDPR outside view
70
Average
66

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website targets pharmaceutical manufacturing professionals and companies, positioning itself as a key information source in this niche. Its business model revolves around content delivery, subscriptions, and sponsored webinars or events. The presence of a media kit and innovation awards indicates active engagement with industry stakeholders. The platform leverages partnerships for content and advertising but lacks visible direct contact details, relying on forms. Growth potential is supported by diversified content formats and a consistent brand presence across social media. However, the domain registration inconsistency could impact credibility if not addressed.

Security posture

The site employs HTTPS with strong SSL configuration and standard security headers, indicating a good baseline security posture. Cookie consent is managed via OneTrust, supporting GDPR compliance. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of a published security policy, incident response contacts, and vulnerability disclosure reduces transparency and preparedness perception. The missing WHOIS data is a critical concern, potentially indicating domain registration issues that could affect trust. Overall, security maturity is moderate but can be improved with clearer policies and disclosures.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and compliance.
  2. Provide explicit incident response contact information, including abuse and security emails.
  3. Implement and publicize a vulnerability disclosure program or security.txt file.
  4. Enhance accessibility features to improve compliance and user experience.
  5. Regularly audit and update third-party scripts and tracking tools to mitigate vulnerabilities.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Pharma Manufacturing
Description
Pharma Manufacturing provides news, analysis and examples of how leading pharmaceutical companies are tackling drug development, scale-up and manufacturing challenges.
Key services
Industry news, Webinars, Podcasts, Ebooks, Magazine, Newsletter subscriptions
Content quality
good
Branding
consistent

Technology

Stack
JavaScript, Vue.js, Nuxt.js, OneTrust (cookie consent), Google Tag Manager (likely), Content Delivery Network (CDN)
Frameworks
Vue.js, Nuxt.js
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism
  • No exposed sensitive data in HTML
  • Use of security headers

Analytics and tracking

Services
Google Analytics (likely)
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Google Ad Manager
Tracking pixels
OneTrust
Marketing tools
OneTrust
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website content is fully accessible and professional.
  2. No WAF or blocking mechanisms detected.
  3. WHOIS data missing, indicating potential domain registration issues.
  4. Privacy and cookie policies are present and compliant.
  5. No direct contact emails or phone numbers found in HTML; contact via form only.
  6. Use of modern JavaScript frameworks and cookie consent tools.
  7. Social media presence on Facebook, Twitter, LinkedIn.
  8. No explicit security policy or incident response info published.
  9. No vulnerability disclosure or security.txt found.
  10. No adult or questionable content detected.
Technical notes

Notes

The website is built using modern JavaScript frameworks Vue.js and Nuxt.js, enabling server-side rendering and good SEO. It uses OneTrust for cookie consent management and likely integrates Google Analytics for traffic analysis. The site loads multiple CSS and JS modules asynchronously, indicating a modular architecture. Performance is moderate, with good mobile responsiveness and basic accessibility. The hosting provider is not explicitly identified. There is no evidence of legacy or vulnerable libraries. Technical risks include dependency on third-party scripts and the need for continuous monitoring of security and performance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with pharmamanufacturing.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review pharmamanufacturing.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.